Hahaha! I agree that both are high risk, high reward. The difference is that biotech companies semi-regularly produce products that large numbers of people use and derive benefits from. Not saying that won’t happen with Quantum Computing, but QC has felt like was 10 years away for about 10 years now.

The difference is of course that there are biotech applications. There won't be any QC applications for decades to come.

If you believe any company today doing QC stuff will earn money ever, you're playing the really long game.

Some of the main players, like IBM, are not VC-funded companies.